On 12 December, the Brazilian PTO (BPTO) patent division issued a statement explaining that the patent application examination queue will be based...
OUR TEAM
Kene Gallois
Head of the Chemical & Life Sciences Group
Kene Gallois has more than 10 years experience in the field of Biological Sciences. She graduated from the Fluminense Federal University (UFF) and has a Master’s Degree from the Oswaldo Cruz Foundation (Fiocruz) in Cellular and Molecular Biology. She began her career working in research projects in Pathology, Immunology and Pharmacology and has been working with patents in the areas of Biotechnology, Pharmacy, Chemistry, Agriculture, Food and Cosmetics since 2009, providing specialized counseling to clients.
In 2015, she joined Daniel Law, where she coordinates the Life Sciences Division, providing several services related to the patent practice, such as drafting, filing and processing patent applications, performing searches, providing technical assistance in Court actions, preparing legal opinions and freedom-to-operate reports, analyzing the client’s portfolios and providing assistance on commercial strategies. She also attends meetings with clients and the Brazilian PTO examiners and trains newly-hired professionals, amongst other responsibilities.
Practice Areas
Biotechnology
Patents
Pharma
Chemistry
Patents
Pharma
Chemistry
Education
Master’s Degree in Molecular and Cellular Biology from the Oswaldo Cruz Foundation (Fiocruz);
Graduation in Biological Sciences from the Fluminense Federal University (UFF).
Graduation in Biological Sciences from the Fluminense Federal University (UFF).
Affiliations, Commissions and Collegiate
Member of the Brazilian Intellectual Property Association – ABPI;
Member of the Regional Council of Biology – CRBio-02.
Member of the Regional Council of Biology – CRBio-02.
Languages
Portuguese and English.
Articles
Interministerial Group on Intellectual Property (GIPI) approves the National Intellectual Property Strategy (ENPI) action plan for 2023-2025
Rule GIPI/MDIC No. 8, of October 18, 2023, comprising an action plan for the next biennium involving the Brazilian Patent and Trademark Office, was...
Insights for patent protection of car-t cells-related technologies in Brazil
Chimeric antigen receptor (CAR) T-cell therapy is a personalised cancer treatment that is gaining greater visibility and enthusiasm as research...
ANVISA prohibits importation of the Cannabis plant in natura
Through Technical Note No. 35/2023, ANVISA (the Brazilian National Agency for Sanitary Surveillance – the Brazilian FDA) prohibited the importation...
Prior Art and Patentability (Brazil)
A Practice Note addressing prior art and patentability in Brazil, which affects the scope of protection of any patent granted in Brazil. It provides...
Cannabis for Therapeutic Purposes in Brazil: Recent Developments and Future Perspectives
It is not news that cannabis-based medicines have been used for millennia around the world in the treatment of conditions and diseases such as...
Divisional applications in Brazil: a brief comparison with other jurisdictions
Similar to other jurisdictions, divisional applications are also a useful tool when considering patent strategy in Brazil. The objective of this...
New cycle of PPH requests starts in January 2023
On January 01, 2023, a new cycle of requests to participate in the Patent Prosecution Highway (PPH) Program began. The PPH program is a bilateral...
Standard ST.26 implementation for Sequence Listing files in Brazil: particularities
As previously informed, the transition of Sequence Listing files from Standard ST.25 to Standard ST.26 began last Friday (July 1st, 2022),...
Brazilian PTO announces additional clarifications on the implementation of Sequence Listing files in Standard ST.26
Continuing our previous communications on the transition of Sequence Listing files from Standard ST.25 (.txt) to the Standard ST.26 (.xml) for...
The impacts of ending ANVISA’S participation in the examination of Brazilian patent applications
About a month after the publication of Law # 14,195/21, which revoked Article 229-C of the Brazilian IP Law, it is already possible to observe...
Biological Sequence Listing Using XML in Patent Applications: Implementation Plan And Main Modifications
At the end of 2020, the Brazilian PTO published Ordinance PR # 405 with new rules for presenting the Sequence Listing files as part of biotechnology...
What to expect from the examination of cannabinoid patent applications after ruling out ANVISA’s interference
Brazilian law # 14,195/21 revoking Article 229-C of the Brazilian IP Law was recently sanctioned by the Presidency, leading to intense debate on how...
Major development in the prosecution of life sciences patents in Brazil: ANVISA is kicked out of the process
After being sanctioned by the Presidency, a Brazilian statute suppressing the role played by the National Health Surveillance Agency – ANVISA (the...
Experimental Data: A Key Element of Brazilian Medical Use Claims
There is no doubt that it is a challenge to design a patent protection strategy for a new medical use (for example, a new disease to be treated or...
Brazil’s Patent System: Latest Statistics on Efforts to Reduce the Backlog and the Road Ahead
“The plan to combat the backlog in the Brazilian Patent and Trademark Office has already resulted in a reduction of more than 60% of patent...
Backlog combat programme: Brazilian PTO reaches its highest patent decision indicators
The issue of reducing the backlog of the examination of patent applications has become a priority for the Brazilian PTO. In 2019, a programme aiming...
The Nagoya Protocol enters into force in Brazil
The final stage was concluded on March 04, 2021: Brazil ratified the Nagoya Protocol, a multilateral agreement supplementary to the Convention on...
New Guidelines for Biotech Inventions are Published by the Brazilian PTO
The Brazilian PTO published today, December 1, 2020, new Guidelines for Examination of patent applications in the Biotechnology field (Rule #...
A Look at BPTO Data on Pharmaceutical Patents Subject to the Minimum Term of Ten Years From Grant
A key issue of discussion with respect to the Brazilian patent system has to do with patents granted by the Brazilian Patent and Trademark Office...
Brazilian Ministry of Health creates IP advisory groups that may interfere in examining patent applications
Through Ordinance #2,466/2020, published on October 15, 2020, two (2) Intellectual Property advisory groups were created with the objective of...
Brazilian Ministry of Health Accelerates Examination of Pharma Patent Applications
The Brazilian Patent and Trademark Office (BPTO) presently offers more than 15 programs to speed up examination of patent applications. The...
How can foreign companies regularize activities from access to national genetic heritage?
Brazilian authorities seek to reduce bureaucratic processes and regularize activities resulting from access to biodiversity. With these efforts, on...
Patent applications related to COVID-19 are eligible for accelerated examination at the Brazilian PTO
In complement of Rule # 239 of June 4, 2019, which governs the priority examination request program, the Brazilian PTO published today (April 7,...
Divisional applications: Procedural manoeuvres pay off
In complement of Rule # 239 of June 4, 2019, which governs the priority examination request program, the Brazilian PTO published today (April 7,...
How to protect therapeutic methods in Brazil
Brazil’s patent law does not allow methods of treatment to be patented, but there are other means of getting protection, according to Kene Gallois...
The Brazilian PTO launched a public consultation inviting comments on patent applications in the biotechnology field
The Brazilian PTO published today a draft version of guidelines for the examination of patent applications in the biotechnology field. Any comments...
Patent backlog in Brazil: slow, but welcome, progress
In 2017, the number of pending patent applications awaiting a final decision was reduced by 7.6%. The backlog reduction was the result of a...
PPH between BRPTO and UKIPO on Biotech and Telecom fields
The Brazilian Patent Office (BRPTO) published on July 24, 2018, Rule # 222/2018, which establishes the procedures related to the Patent Prosecution...
Rare diseases, Chikungunya and Zika are now possibilities for fast-track examination request
The Brazilian PTO published on May 9th, 2018 Rule # 217/2018, which modifies former Rule # 80/2013 related to the fast-track examination of patent...
BPTO extends the period for requesting priority examination under the PPH with the USPTO
n complement of Rule # 154 of December 21, 2015, the Brazilian PTO published today (January 30, 2018) Rule # 210/2018 of January 26, 2018, which...
Updates on the requirements concerning access to components of Brazil’s genetic heritage or traditional Knowledge
Since November 26, 2015, Applicants declare, when filing a patent application in Brazil, if the claimed invention derives or not from access to...
Phase II of USPTO-BPTO PPH: new requirements and extension of the covered technical field
The Brazilian PTO published on May, 9th Rule # 218/2018, which establishes the second phase of the Patent Prosecution Highway (PPH) between the...
BRPTO’s establishes guidelines for examining chemical patent applications
The Brazilian PTO published in January 2nd Rule 208/2017, which provides guidelines for the examination of patent applications related to the...
Biotechnology Patents in Brazil: Current Situation and Expectations
Biotechnology is a multidisciplinary science that integrates concepts of Biology, Chemistry, Engineering and Informatics, based on the use of living...
Brazil x Europe – A Comparative Study as to Antibody Patentability
Despite the ongoing efforts to harmonize patent practice in all countries, some differences persist. When it comes to technological domains, like...
Main Aspects of Plant Protection in Brazil and its Changes Over These Twenty Years
Plant variety protection (PVP) was discussed in Brazil for the first time in 1976 with the intention of drafting a law that would regulate...
BRPTO launched a public consultation inviting comments on chemical patents application
The Brazilian PTO published a draft guidelines for the examination of patent applications related to the chemical field (please find enclosed an...
BRPTO and ANVISA’s role regarding the examination of pharma patents application
On April 12, 2017, Brazilian PTO and ANVISA (Brazilian Health Surveillance Agency) signed the Joint Ordinance # 1/2017, which regulates the...
Bridging the great divide
Since 2001, the grant of pharmaceutical-related patent applications in Brazil has come to depend on a prior approval analysis by the Brazilian...
The Most Important Aspects of Protecting Your Biotechnology Invention in Brazil
Biotechnology is a fascinating industry involving genetic research, animal and human health care issues, the development of innovative bio...